obesity

Wegovy and Ozempic stars dim amid overuse concerns
Axios
Tue, 02/11/25 - 11:17 am
Wegovy
Ozempic
Zepbound
Mounjaro
Novo Nordisk
Eli Lilly
GLP-1 agonists
obesity
patients
physicians
side effects
Novo Nordisk plans new study for CagriSema, targets 2026 submission
Clinical Trials Arena
Fri, 02/7/25 - 11:42 am
Novo Nordisk
CagriSema
obesity
clinical trials
Amgen's early-stage obesity asset slapped with FDA hold
Fierce Biotech
Wed, 02/5/25 - 11:27 am
Amgen
FDA
clinical trials
obesity
AMG 513
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
Motley Fool
Mon, 02/3/25 - 11:55 am
Novo Nordisk
obesity
amycretin
Novo Nordisk commences fresh trials for CagriSema
Devdiscourse
Thu, 01/30/25 - 11:33 am
Novo Nordisk
CagriSema
clinical trials
obesity
Versant invests again in obesity, this time backing Helicore Biopharma
BioPharma Dive
Tue, 01/28/25 - 10:44 am
Versant Ventures
obesity
Helicore Biopharma
funding
Veru's drug conserves muscle mass for older patients taking Novo's Wegovy in phase 2 trial
Fierce Biotech
Tue, 01/28/25 - 10:17 am
Veru
obesity
Novo Nordisk
enobosarm
Metsera eyes $289M IPO to fund phase 3 weight loss trial
Fierce Biotech
Mon, 01/27/25 - 11:32 am
Metsera
obesity
IPOs
GLP-1 agonists
MET-097i
Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%
Fierce Biotech
Fri, 01/24/25 - 11:47 am
Novo Nordisk
amycretin
obesity
clinical trials
After an obesity stumble, BioAge reconnects with its longevity pipeline
Pharma Voice
Wed, 01/22/25 - 11:20 am
BioAge Labs
obesity
Novartis
anti-aging
Ascletis Pharma’s ASC30 oral tablet shows promise in obesity trial
Clinical Trials Arena
Tue, 01/21/25 - 11:27 am
Ascletis Pharma
obesity
ASC30
clinical trials
Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
Fierce Pharma
Fri, 01/17/25 - 11:34 am
Novo Nordisk
obesity
semaglutide
Wegovy
Eli Lilly
Zepbound
clinical trials
JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance
Clinical Trials Arena
Tue, 01/14/25 - 09:54 am
JPMHC 2025
Amgen
obesity
Robert Bradway
MariTide
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Investing.com
Mon, 01/13/25 - 05:37 pm
JPMHC 2025
obesity
Pharma CEOs
Albert Bourla
2024 was a record year for obesity trials and 2025 is already poised to take over
Clinical Trials Arena
Mon, 01/13/25 - 11:07 am
clinical trials
obesity
Kailera reports Zepbound-rivaling weight loss in phase 2 obesity trial
Fierce Biotech
Mon, 01/13/25 - 11:01 am
Kailera Therapuetics
obesity
clinical trials
Jiangsu Hengrui Pharmaceuticals
5 questions facing pharma in 2025
BioPharma Dive
Fri, 01/10/25 - 11:47 am
Donald Trump
obesity
Novo Nordisk
Eli Lilly
vaccines
pharma stocks
regulatory
immunology
Verdiva Bio raises $411m for obesity pipeline
Pharmaphorum
Thu, 01/9/25 - 11:06 am
Verdiva Bio
obesity
funding
Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes
Fierce Biotech
Wed, 01/8/25 - 11:23 am
Novo Nordisk
Valo Health
artificial intelligence
diabetes
obesity
3 trial readouts that could shake up the obesity market this year
Pharma Voice
Wed, 01/8/25 - 11:15 am
obesity
weight loss
Metsera
MET-097i
Skye Bioscience
nimacimab
Eli Lilly
orforglipron
clinical trials

Pages